Technological approaches to the synthesis of tripeptide H-Ala-Leu-Gly-OH methods mixed anhydride and activated ester

Authors

  • Khkimzoda Parvina Ubaidullo

Keywords:

tripeptide, H-Ala-Leu-Gly-OH, peptide synthesis, mixed anhydride method, ethyl chloroformate, activated esters, pentafluoroethyl ethers, dicyclohexylurea

Abstract

This paper presents a detailed study of methods for synthesizing the tripeptide H-Ala-Leu-Gly-OH, which is of interest as a model compound for studying peptide condensation processes and the production of biologically active oligopeptides. The focus is on the application of the mixed anhydride method, which utilizes ethyl chloroformate as the condensing reagent. This method effectively activates the carboxyl group and ensures a high degree of selectivity in the interaction with the amino component.

Furthermore, the paper describes in detail an alternative method for synthesizing the tripeptide—the method of activated esters, specifically pentafluoroethyl derivatives. The advantage of this approach is the high reactivity of the resulting activated compounds. A significant technological advantage is that the activated esters were not isolated individually, but were introduced directly into the condensation stage after removal of dicyclohexylurea by simple filtration. This approach significantly reduces the number of intermediate steps, decreases time costs, and minimizes potential loss of substance. The analysis showed that the use of pentafluoroethyl ethers without their isolation in pure form simplifies the process and increases its overall efficiency. The results confirm the potential of combining two methods—mixed anhydrides and activated esters—in the synthesis of short peptides, which could be useful both in research and in the development of new approaches to obtaining biologically active compounds.

References

U.S. Food and Drug Administration (FDA): официальный сайт — URL: https://www.fda.gov/drugs/new drugs-fda-cders-new-molecular-entities-and-new-therapeutic-biological-products/nov-el-drug-approvals-2021 (дата обращения 3 мая 2021).

U.S. Food and Drug Administration (FDA): официальный сайт — URL: https://www.fda.gov/drugs/new drugs-fda-cders-new-molecular-entities-and-new-therapeutic-biological-products/nov-el-drug-approvals-2020 (дата обращения 3 мая 2021).

Beatriz G. de la Torre, Fernando Albericio. Peptide Therapeutics 2.0 // Molecules. 2020. Vol. 25. P. 2293 doi:10.3390/molecules25102293.

Vincent Martin, Peter H. G. Egelund, Henrik Johans son, Sebastian Thordal Le Quement, Felix Wojcik and Daniel Sejer Pedersen. Greening the synthesis of peptide therapeutics: an industrial perspective // RSC Adv. 2020 Vol. 10. P. 42457.

С. М. Филатова*, М. К. Гусева, Т. Г. Бодрова, Д. В. Паршина, У. А. Буданова, Ю. Л. Себякин Эволюционное развитие и структурное разнообразие природных антимикробных пептидов, пептидомиметиков и катионных амфифилов на основе аминокислот рос. хим. ж. (Ж. Рос. хим. об-ва им. Д.И. Менделеева), 2021, т. LXV, № 2. -С.22-34;

Полянский М. А., Гинак А. И. Основные концепции синтеза пептидов как нового поколения биологически активных препаратов Известия СПБГТИ(ТУ) химия и химическая технология · органический синтез и биотехнология №58(84) 2021. -С.62-65;

Vasso Apostolopoulos, Joanna Bojarska, Tsun-Thai Chai, Sherif Elnagdy, Krzysztof Kaczmarek, John Matsoukas, Roger New, Keykavous Parang, Octavio Paredes Lopez, Hamideh Parhiz, Conrad O. Perera, Monica Pickholz, Milan Remko, Michele Saviano, Mariusz Skwarczynski, Yefeng Tang, Wojciech M. Wolf, Taku Yoshiya, Janusz Zabrocki, Piotr Zielenkiewicz, Maha AlKhazindar, Vanessa.

Published

2026-03-21

How to Cite

Хкимзода Парвина Убайдулло. (2026). Technological approaches to the synthesis of tripeptide H-Ala-Leu-Gly-OH methods mixed anhydride and activated ester. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE KYRGYZ REPUBLIC, (11), 277–281. Retrieved from https://ilim.uia.gov.kg/index.php/main/article/view/1219